DeepIntent OS expected to give publishers access to company’s comprehensive suite.
Image Credit: Adobe Stock Images/VICHIZH
DeepIntent, a healthcare advertising technology organization, has announced the launch of the DeepIntent Operating System, designed to provide CTV platforms access to its audience, measurement, and optimization solutions designed to improve pharmaceutical advertising performance.
"For platforms and publishers to unlock the full potential of their inventory, they need flexibility, transparency, control, and outcomes-driven optimization. We've launched DeepIntent OS to give them those tools to help them thrive in the complex pharma landscape. As DeepIntent continues to drive innovation, we remain committed to harnessing technology to connect patients and providers with the right information to drive better health outcomes," said Chris Paquette, founder, CEO, DeepIntent.
Reference:
1. DeepIntent Unveils Operating System to Power Pharmaceutical Advertising for CTV Publishers and Platforms. PR Newswire. June 5, 2023. Accessed June 5, 2023. https://www.prnewswire.com/news-releases/deepintent-unveils-operating-system-to-power-pharmaceutical-advertising-for-ctv-publishers-and-platforms-301841362.html
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.